Atlas Trials

A Study of LY353381 (Arzoxifene) for Patients Who Benefitted From This Drug in Other Oncology Trials and Wished to Continue Treatment

Clinical trial NCT00190697 · COMPLETED

Trial details

NCT number
NCT00190697
Sponsor
Eli Lilly and Company
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Breast CancerEndometrial CancerOvarian Cancer
Start date
2001-01-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.